| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $59.1M | — | +32.1% |
| SG&A Expense | $7.2M | — | -8.2% |
| Operating Income | -$66.3M | — | -26.1% |
| Interest Expense | $4.6M | — | +106.8% |
| Pre-tax Income | -$68.7M | — | -39.3% |
| Income Tax | $95K | — | +117.0% |
| Net Income | -$68.8M | — | -41.1% |
| EPS (Basic) | -$0.20 | — | -25.0% |
| EPS (Diluted) | -$0.20 | — | -25.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Cash & Equivalents | $120.9M | +17.2% | +103.2% |
| Short-term Investments | $311.6M | +11.0% | +36.6% |
| Current Assets | $456.7M | +11.2% | +53.4% |
| Total Assets | $484.3M | +11.4% | +59.2% |
| Current Liabilities | $120.3M | -3.6% | +45.5% |
| Long-term Debt | $299.2M |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$68.1M | — | -173.8% |
| Capital Expenditures | $526K | — | +13.4% |
| Investing Cash Flow | -$31.5M | — | -270.1% |
| Financing Cash Flow | $117.1M | — | +1161.9% |
| Free Cash Flow | -$68.6M | — | -170.9% |
| +110.3% |
| Total Liabilities | $428.2M | +37.6% | +87.8% |
| Stockholders' Equity | $56.1M | -54.7% | -26.4% |